In fact, the most potent vasodilator molecule, NO, is found to be decreased in patients with IBD since they have an increase in TNF-alpha and a higher expression of the enzyme arginase, which competes for L-arginine that is catalyzed by endothelial NO synthase [17]. The gene discussed is TNF; the disease is inflammatory bowel disease.